mbtI Resolved · high auto-curated

H37Rv Rv2386c · MTBC0 - · 450 aa · 2678653–2680005 H37Rv (-) · RefSeq YP_177877.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)salicylate synthase
MTBC0 PGAP re-annotation—
Revised (this work)Salicylate synthase. Pfam: Chorismate_bind (PF00425.25).
Functional category (TubercuList)lipid metabolism

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

Annotated on the H37Rv protein: this gene has no 1:1 ancestral MTBC0 anchor (PE/PPE, paralogue, IS element, or otherwise unanchored CDS).

In the literature (TB corpus sweep) 35 publications

35 TB publications mention this gene. 35 publications discuss this gene. Queried separately, 35 records carry a M. tuberculosis context and 2 a non-TB mycobacterial context (species named in the 2-record verified sample: M. abscessus (1), M. smegmatis (1)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 35: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Utilization of a CRISPRi-based ex vivo challenge model to reveal temporally dependent gene essentiality in intracellular Mycobacterium tuberculosis. doi:10.1128/mbio.00610-26 2026
Meta-analysis reveals a core iron-responsive gene signature in Mycobacterium tuberculosis linking siderophore biosynthesis, virulence, and metabolic adaptation. doi:10.1007/s10534-026-00818-6 2026
Halting Tuberculosis in Its Tracks: Advances and Strategies for Discovering Therapeutic Targets in Mycobacterium tuberculosis. doi:10.1002/ddr.70239 2026
Analyzing the distribution of virulence factors of Mycobacterium tuberculosis and the impact of virulence gene mutations on treatment outcomes in different lineages using whole-genome sequencing in Urumqi. doi:10.1080/21505594.2025.2552875 2025
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy. doi:10.1021/acs.jmedchem.4c02386 2025
35 records returned by the alias sweep

Searched as: Rv2386c, mbtI, Mb2407c, MMAR_3706, MSMEG_4524, MAB_2245 — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Utilization of a CRISPRi-based ex vivo challenge model to reveal temporally dependent gene essentiality in intracellular Mycobacterium tuberculosis. doi:10.1128/mbio.00610-26 mBio 2026
Meta-analysis reveals a core iron-responsive gene signature in Mycobacterium tuberculosis linking siderophore biosynthesis, virulence, and metabolic adaptation. doi:10.1007/s10534-026-00818-6 Biometals 2026
Halting Tuberculosis in Its Tracks: Advances and Strategies for Discovering Therapeutic Targets in Mycobacterium tuberculosis. doi:10.1002/ddr.70239 Drug Dev Res 2026
Analyzing the distribution of virulence factors of Mycobacterium tuberculosis and the impact of virulence gene mutations on treatment outcomes in different lineages using whole-genome sequencing in Urumqi. doi:10.1080/21505594.2025.2552875 Virulence 2025
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy. doi:10.1021/acs.jmedchem.4c02386 names it J Med Chem 2025
Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery. doi:10.3390/ph16111559 names it Pharmaceuticals (Basel) 2023
Targeting Mycobacterium tuberculosis iron-scavenging tools: a recent update on siderophores inhibitors. doi:10.1039/d3md00201b RSC Med Chem 2023
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria. doi:10.3390/pharmaceutics15020502 Pharmaceutics 2023
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections. doi:10.3390/ph15080992 names it Pharmaceuticals (Basel) 2022
Approaches for targeting the mycobactin biosynthesis pathway for novel anti-tubercular drug discovery: where we stand. doi:10.1080/17460441.2022.2077328 Expert Opin Drug Discov 2022
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents. doi:10.3390/ph14020155 names it Pharmaceuticals (Basel) 2021
The Mycobactin Biosynthesis Pathway: A Prospective Therapeutic Target in the Battle against Tuberculosis. doi:10.1021/acs.jmedchem.0c01176 J Med Chem 2021
Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design. doi:10.1021/acs.jmedchem.0c00373 names it J Med Chem 2020
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents. doi:10.1080/14756366.2019.1589462 names it J Enzyme Inhib Med Chem 2019
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents. doi:10.1016/j.ejmech.2018.06.033 names it Eur J Med Chem 2018
New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies. doi:10.3390/molecules23071506 names it Molecules 2018
Genome-wide DNA methylation and transcriptome changes in Mycobacterium tuberculosis with rifampicin and isoniazid resistance. Int J Clin Exp Pathol 2018
Synthesis of Transition-State Inhibitors of Chorismate Utilizing Enzymes from Bromobenzene cis-1,2-Dihydrodiol. doi:10.1021/acs.joc.6b02801 J Org Chem 2017
Integration of ligand and structure based approaches for identification of novel MbtI inhibitors in Mycobacterium tuberculosis and molecular dynamics simulation studies. doi:10.1016/j.jmgm.2016.09.004 names it J Mol Graph Model 2016
Iron Acquisition Pathways as Targets for Antitubercular Drugs. doi:10.2174/0929867323666160607223747 Curr Med Chem 2016
Stereocontrolled Synthesis of a Potential Transition-State Inhibitor of the Salicylate Synthase MbtI from Mycobacterium tuberculosis. doi:10.1021/acs.joc.5b00455 names it J Org Chem 2015
Lysine221 is the general base residue of the isochorismate synthase from Pseudomonas aeruginosa (PchA) in a reaction that is diffusion limited. doi:10.1016/j.abb.2013.07.026 Arch Biochem Biophys 2013
Synthesis and evaluation of M. tuberculosis salicylate synthase (MbtI) inhibitors designed to probe plasticity in the active site. doi:10.1039/c2ob26736e names it Org Biomol Chem 2012
Implications of binding mode and active site flexibility for inhibitor potency against the salicylate synthase from Mycobacterium tuberculosis. doi:10.1021/bi3002067 Biochemistry 2012
Understanding the different activities of highly promiscuous MbtI by computational methods. doi:10.1039/c2cp23149b names it Phys Chem Chem Phys 2012
Toxicogenomic response of Mycobacterium bovis BCG to peracetic acid and a comparative analysis of the M. bovis BCG response to three oxidative disinfectants. doi:10.1007/s00253-010-2931-6 Appl Microbiol Biotechnol 2011
Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening. doi:10.1002/cmdc.201000275 names it ChemMedChem 2010
Inhibition studies of Mycobacterium tuberculosis salicylate synthase (MbtI). doi:10.1002/cmdc.201000137 names it ChemMedChem 2010
Structure and mechanism of MbtI, the salicylate synthase from Mycobacterium tuberculosis. doi:10.1021/bi060852x names it Biochemistry 2007
The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin, reveals it to be a salicylate synthase. doi:10.1128/JB.00338-06 names it J Bacteriol 2006
Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. doi:10.1002/eji.200535496 Eur J Immunol 2006
Crystallization and preliminary X-ray crystallographic analysis of MbtI, a protein essential for siderophore biosynthesis in Mycobacterium tuberculosis. doi:10.1107/S1744309104031215 names it Acta Crystallogr Sect F Struct Biol Cryst Commun 2005
Both Corynebacterium diphtheriae DtxR(E175K) and Mycobacterium tuberculosis IdeR(D177K) are dominant positive repressors of IdeR-regulated genes in M. tuberculosis. doi:10.1128/IAI.73.9.5988-5994.2005 Infect Immun 2005
The Mycobacterium tuberculosis IdeR is a dual functional regulator that controls transcription of genes involved in iron acquisition, iron storage and survival in macrophages. doi:10.1046/j.1365-2958.2001.02684.x Mol Microbiol 2001
Identification of a Mycobacterium tuberculosis gene cluster encoding the biosynthetic enzymes for assembly of the virulence-conferring siderophore mycobactin. doi:10.1016/s1074-5521(98)90291-5 Chem Biol 1998

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Conditional expression context (iModulons)

Member of 1 independently-modulated gene set(s): IdeR (ideR).

iModulon membership (independently-modulated gene sets from a 647-sample RNA-seq compendium): the conditional co-expression context. Co-expression is a regulatory context, NOT a molecular function. Source: iModulonDB / modulome_mtb (Yoo 2022).

CRISPRi vulnerability

Vulnerability index -0.42 (95% CI -0.57 to -0.30). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInvolved in the biogenesis of the hydroxyphenyloxazoline-containing siderophore mycobactins. Possibly plays a role in the conversion of chorismate to salicilate (the starter unit for mycobactin siderophore construction).
Mycobrowser EC 4.1.3.-, 5.4.4.2 · agrees with the atlas

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb2407c · 99.8% identity
M. marinum MMAR_3706 · 78.3% identity
M. smegmatis MSMEG_4524 · 67.4% identity
M. orygis RJtmp_002464 · 99.8% identity
M. abscessus MAB_2245 · 63.9% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WFX1 SwissProt · reviewed · Evidence at protein level
UniProt nameSalicylate synthase
EC (curated) EC 4.2.99.21, EC 5.4.4.2, EC 5.4.99.5
Curated functionInvolved in the incorporation of salicylate into the virulence-conferring salicylate-based siderophore mycobactin. Catalyzes the initial conversion of chorismate to yield the intermediate isochorismate (isochorismate synthase activity), and the subsequent elimination of the enolpyruvyl side chain to give salicylate (isochorismate pyruvate-lyase activity). In the absence of magnesium, MbtI displays a chorismate mutase activity and converts chorismate to prephenate.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category H Coenzyme transport and metabolism
Q Secondary metabolites biosynthesis, transport and catabolism
Preferred namembtI
eggNOG descriptionconversion of chorismate to
Orthologous groupCOG1169
EC number EC 4.2.99.21, EC 5.4.4.2
KEGG orthology K04781
KEGG pathways map01053, map01110, map01130
Gene Ontology (146) GO:0000162, GO:0000287, GO:0003674, GO:0003824, GO:0004049, GO:0004106, GO:0005488, GO:0005575, GO:0005622, GO:0005623, GO:0005737, GO:0005886 +134 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.727 · quasi-invariant (6 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 2 synonymous, 4 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

Genus-wide presence (~53 non-MTBC Mycobacterium) present in 52/53 (98%) · mean identity 73.5% · 4/4 closest MTBAP relatives
conserved across the genus (present in 52/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 8/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 41.4%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) GD — not strictly essential

The two screens disagree on this gene: Tn-seq says growth-defect (insertions tolerated, NOT essential) (GD), CRISPRi says essential.

Two genome-wide screens disagree on this gene, and both are kept as they stand. They do not measure the same thing: the Tn-seq call (DeJesus 2017) reports tolerance to transposon insertion across the ORF, the CRISPRi call (Bosch 2021) reports tolerance to partial knockdown. A gene can absorb an insertion and still be required at full dosage, or the reverse. Here the CRISPRi estimate is a confident one (its `certain` flag is set, vulnerability index -0.423), so the disagreement is a genuine methodological tension rather than a weak fit. Atlas-wide, 89 gene(s) fall in this exact stratum, out of 193 showing this direction of disagreement.

DeJesus 2017 callGD · growth-defect
What the call meansgrowth-defect: insertions tolerated but fitness reduced; NOT essential
TA sites (Himar1) 19 in the ORF — 0 in the essential state, 15 growth-defect, 4 non-essential, 0 growth-advantage. Saturation 0.684, mean read count 18.5384615385. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 19 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.
Caveat`essential: true` here is the broad union (ES+ESD+GD) kept for backward compatibility; this gene is NOT strictly essential. Read n_sites_* before writing anything about essentiality.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Mutant phenotypes (conditional Tn-seq, MtbTnDB) in-vivo phenotype

Conditionlog2FCqEffect
fitness in mouse infection, day 45 (in vivo) -7.060.007 required
altered fitness under 6 weeks hypoxia (stress) -2.870.016 required

Conditional fitness of transposon-disruption mutants across 2 significant condition(s) (|log2FC|≥1, q≤0.05), from the standardized MtbTnDB compendium. A negative log2FC means the mutant is depleted — the gene contributes to fitness in that condition. An in-vivo defect for a "hypothetical" is strong evidence it matters for infection, even without a known molecular function. Disruption (Tn insertion), not a clean deletion; genetic-interaction screens excluded.

Proteomics (mass spectrometry) detected

MS detectiondetected in 11 of 16 independent MS datasets
Integrated abundance20.8 ppm · rank 2321/3519 (34.1th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length450 aa
Molecular weight48.8 kDa
Theoretical pI5.21
GRAVY-0.038 (hydrophilic)
Aliphatic index97.6
Aromaticity0.058
Instability index44.0 (unstable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
Chorismate_bindPF00425.25 2.4e-69185–438 chorismate binding enzyme

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 8qn5 (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 14 solved

PDBMethodResolutionCoverage
8qn5 X-ray diffraction 1.544 Å 100%
8qc4 X-ray diffraction 1.578 Å 100%
3log X-ray diffraction 1.73 Å 100%
3st6 X-ray diffraction 1.75 Å 100%
2g5f X-ray diffraction 1.8 Å 100%
6za6 X-ray diffraction 1.804 Å 100%
3veh X-ray diffraction 2.0 Å 100%
3rv6 X-ray diffraction 2.04 Å 100%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (14 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 93.9

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
8qc4-assembly1_A 1.00 0.98 0.95 0.98 100% 97% / 100% 4.0e-83 sig 8qc4-assembly1_A M. tuberculosis salicylate synthase MbtI in complex with 5-(3-carboxyphenyl)furan-2-carboxylic acid
6za4-assembly1_A 1.00 0.99 0.94 0.99 99% 97% / 100% 6.8e-81 sig 6za4-assembly1_A M. tuberculosis salicylate synthase MbtI in complex with 5-(3-cyanophenyl)furan-2-carboxylate
3veh-assembly4_D 1.00 0.99 0.96 0.99 100% 98% / 100% 8.5e-81 sig 3veh-assembly4_D Structure of a M. tuberculosis salicylate synthase, MbtI, in complex with an inhibitor methylAMT
6za4-assembly4_D 1.00 0.99 0.94 0.99 99% 96% / 100% 1.5e-80 sig 6za4-assembly4_D M. tuberculosis salicylate synthase MbtI in complex with 5-(3-cyanophenyl)furan-2-carboxylate
3rv8-assembly2_B 1.00 0.99 0.95 0.99 99% 97% / 100% 2.1e-80 sig 3rv8-assembly2_B Structure of a M. tuberculosis Salicylate Synthase, MbtI, in Complex with an Inhibitor with Cyclopropyl R-Group

Foldseek search of the AlphaFold DB model (mean pLDDT 93.9, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon)

Upstream (5' on genome)mbtJ (+ strand, 3 bp gap)
Downstream (3' on genome)Rv2386a (+ strand, 452 bp gap)

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton)
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT2454) expressed, no multi-gene operon (exponential phase, coverage 17.1)
not expressed (stationary phase) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: trpG (anthranilate synthase component II), high confidence (score 993, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair's experimental or database support is transferred from orthologous pairs in other proteomes only: nothing was measured in M. tuberculosis, so it is an association inferred by orthology rather than measured in this organism.

Showing the 15 strongest of this gene's 41 partners at medium confidence (26 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 41 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv0013 trpG exp (transferred) anthranilate synthase component II 996 993 ctx fusion:529 cooccurence:770 coexpression:694 experimental:788 textmining:479
Rv2192c trpD exp (transferred) anthranilate phosphoribosyltransferase 991 984 ctx cooccurence:762 coexpression:694 experimental:778 textmining:506
Rv2384 mbtA 2,3-dihydroxybenzoate-AMP ligase 998 971 ctx fusion:838 coexpression:810 textmining:946
Rv1611 trpC exp (transferred) indole-3-glycerol phosphate synthase 973 957 ctx cooccurence:766 coexpression:646 experimental:461 textmining:416
Rv2383c mbtB phenyloxazoline synthase 996 932 coexpression:866 textmining:946
Rv3215 entC curated paralog isochorismate synthase 942 929 database:900
Rv1612 trpB tryptophan synthase subunit beta 953 925 ctx cooccurence:737 coexpression:691 textmining:411
Rv1613 trpA tryptophan synthase subunit alpha 958 922 ctx cooccurence:761 coexpression:648 textmining:487
Rv2540c aroF curated chorismate synthase 944 910 ctx cooccurence:441 database:800 textmining:410
Rv2552c aroE curated shikimate 5-dehydrogenase 902 865 database:800
Rv1609 trpE curated paralog anthranilate synthase component I 872 857 database:800
Rv3402c hypothetical protein 913 831 coexpression:831 textmining:510
Rv2382c mbtC polyketide synthetase 978 825 coexpression:819 textmining:880
Rv0948c curated chorismate mutase 836 811 database:800
Rv1885c curated chorismate mutase 835 811 database:800

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Annotation from H37Rv (no MTBC0 1:1 anchor; H37Rv protein used): salicylate synthase
  • Pfam (hmmscan --cut_ga): Chorismate_bind PF00425.25 (E=2e-69)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq YP_177877.1)
  • Domains: Pfam-A via hmmscan --cut_ga — Chorismate_bind (PF00425.25)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG1169
  • Curated reference: UniProt P9WFX1 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 93.9)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 41 functional partner(s); context anchor trpG
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Mutant phenotypes: standardized Tn-seq compendium MtbTnDB (Jinich et al. 2025, doi:10.1111/mmi.15370), aggregating many primary Tn-seq studies across conditions
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>H37Rv|Rv2386c|mbtI
MSELSVATGAVSTASSSIPMPAGVNPADLAAELAAVVTESVDEDYLLYECDGQWVLAAGVQAMVELDSDELRVIRDGVTRRQQWSGRPGAALGEAVDRLLLETDQAFGWVAFEFGVHRYGLQQRLAPHTPLARVFSPRTRIMVSEKEIRLFDAGIRHREAIDRLLATGVREVPQSRSVDVSDDPSGFRRRVAVAVDEIAAGRYHKVILSRCVEVPFAIDFPLTYRLGRRHNTPVRSFLLQLGGIRALGYSPELVTAVRADGVVITEPLAGTRALGRGPAIDRLARDDLESNSKEIVEHAISVRSSLEEITDIAEPGSAAVIDFMTVRERGSVQHLGSTIRARLDPSSDRMAALEALFPAVTASGIPKAAGVEAIFRLDECPRGLYSGAVVMLSADGGLDAALTLRAAYQVGGRTWLRAGAGIIEESEPEREFEETCEKLSTLTPYLVARQ